Clinical Trial Update: Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Taxotere with Adriamycin/Cytoxan (AC) in breast cancer patients; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Taxotere (docetaxel)

Snippet

Sponsor: Mothaffar Rimawi | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-06-06